Impairment of Methotrexate Transport Is Common in Osteosarcoma Tumor Samples
Figure 1
Summary of percentage PT430 displacement by methotrexate and trimetrexate in 69 osteosarcoma patient samples. Methotrexate displacement of PT430 was less than 20% in 99% of the samples.
